arXiv:2607.06583v1 Announce Type: cross Abstract: DNA methylation (DNAm) serves as one of the most robust molecular biomarkers of biological aging. While conventional epigenetic clocks accurately predict chronological age from high-dimensional CpG profiles, they treat aging as a static regression task, meaning they can only output a single score rather than simulating how an entire profile continuously changes over time. To reconstruct these continuous dynamics, we frame lifelong human epigenetic aging as a trajectory inference problem across discrete age snapshots derived from widely availabl
Advances in AI and machine learning, particularly in trajectory inference, are enabling new computational approaches to biological data, making this type of analysis feasible now.
This research provides a more dynamic and continuous understanding of the aging process at a molecular level, moving beyond static age prediction to continuous biological simulation.
The ability to model the continuous trajectory of human aging from DNA methylation rather than just predicting a static age score opens pathways for more precise interventions and personalized medicine.
- · Longevity R&D
- · Personalized Medicine
- · Biopharmaceutical Industry
- · AI in Healthcare
- · Traditional age-regression diagnostics
- · Static biomarker-based health assessments
More accurate and dynamic biological aging metrics become available for research and clinical use.
Improved understanding of aging pathways could lead to novel therapeutic targets for age-related diseases.
Enhanced ability to predict individual health trajectories and intervene proactively, significantly extending healthy human lifespan.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG